The current spotlight on the human metapneumovirus (HMPV) — discovered for the first time in 2001 — a longstanding ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...

With cases of HMPV surging in China, people are fearing a Covid-like pandemic hitting the UK – but how worried should we be?

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare ...

"The acquisition of Vectura reflects our commitment to advancing industry-leading medical capabilities for our customers," said Joe Nelligan, CEO, Molex, which acquired Phillips Medisize in 2016.

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...